Hypofractionated radiotherapy as definitive treatment of stage i non-small cell lung cancer in older patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 3, 2011, Pages 254-258

  Ahmad, Ehatsham ^a   Sandhu, Ajay P ^a   Fuster, Mark M ^a   Messer, Karen ^a   Pu, Minya ^a   Nobiensky, Polly ^a   Bazhenova, Lyudmila ^a   Seagren, Stephen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypofractionated radiotherapy; non small cell lung cancer; older age; stage I

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79958287258     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181dea7a3     Document Type: Article

References (21)

1. Herbst RS, Heymach JV, Lippman SM. Lung Cancer. N Engl J Med. 2008;359:1367-1380.
2. Surveillance, Epidemiology and End Results (SEER) Program, National Cancer Institute. Available at: http://seer.cancer.gov.
3. Alberg AJ, Ford JG, Samet JM; American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(suppl 3):29S-55S.
4. Scott WJ, Howington J, Movsas B. Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:234S-242S.
5. Basche M, Kelly K. Treatment of non-small-cell lung cancer in older persons. Oncology (Williston Park). 2003;17:31-39; discussion 43-44, 47-48.
6. Gridelli C, Maione P, Rossi A. Treatment of stage I-III non-small-cell lung cancer in the elderly. Oncology (Williston Park). 2006;20:373-380. (Pubitemid 46940194)
7. Rosenzweig KE, Dladla N, Schindelheim R, et al. Three-dimensional conformal radiation therapy (3D-CRT) for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2001;3:141-144. (Pubitemid 33138779)
8. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685-692.
9. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small-cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer. 2004;101:1623-1631. (Pubitemid 39318910)
10. Pintilie M. Competing Risks: A Practical Perspective. Chichester, United Kingdom: John Wiley & Sons Ltd; 2006.
11. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics. 1982;28:29-41.
12. Raz DJ, Zell JA, Ou SI, et al. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193-199. (Pubitemid 47068221)
13. Noordijk EM, Clement EP, Hermans J, et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol. 1988;13:83-89.
14. Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer. 1980;45:698-702. (Pubitemid 10174611)
15. Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev. 1989;16:247-255. (Pubitemid 20205944)
16. Decker RH, Tanoue LT, Colasanto JM, et al. Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities. Oncology (Williston Park). 2006;20:899-905. (Pubitemid 46940148)
17. Kong FM, Ten Haken R, Schipper M, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324-333. (Pubitemid 41317147)
18. Colice GL, Shafazand S, Griffin JP, et al; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(suppl 3):161S-77S. (Pubitemid 47502806)
19. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60: 615-623.
20. Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943-1951. (Pubitemid 38020756)
21. Brock J, Ashley S, Bedford J, et al. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. Clin Oncol (R Coll Radiol). 2008;20:666-676.